2. DEFINATIONS
Adverse drug reactions (WHO):
Any response to a drug that is noxious and unintended
and that occurs at doses used in man for prophylaxis,
diagnosis or therapy of disease or modification of
physiological states.
3. No Drugs are
Dangerous if
used properly
All Drugs are
Dangerous
Some drugs
have a low
therapeutic ratio
Some drugs have a
low incidence of
horrendous effects
Some drugs are
dangerous in
acute poisoning
but not when
used
therapeutically
The most
dangerous drugs
have the greatest
potential for
benefit
Some adverse
effects occur
after a delay or
after stopping
BAD
GOOD
How dangerous a drug is
depends on the skill of the
prescriber
Some adverse
effects can be
predicted if you
know the
pharmacology
(Type A); some
are not (Type B)
4. The Risk to Benefit Ratio
When prescribing drugs a doctor must assess
risk to benefit ratio in the individual patient by
âąChoosing an appropriate class of drug then an
appropriate individual agent
RISK
BENEFIT
âąIs it effective ?
âąWhat are the chances of adverse effect ?
âąAre there features in this patient which
affect choice eg other drugs, organ failure,
aged
âąTailoring the dose
âąConsidering duration of treatment
5. Epidemiology
4% of hospital admissions
1 in 1000 deaths in medical wards
10 to 20 % of in-patients
5% of patients in general practice
6. More frequent in elderly:
erratic drug taking
multiple pathology
altered pharmacokinetics
increased sensitivity of CNS
and CVS
8. Occur in circumstances related to
drugâs pharmacology, predisposing
factors in the patient and care taken
in choosing the drug and the dose.
9.
10.
11.
12. ï±SIDE EFFECTSï Pharmacological effects produced with therapeutic dose of drug.
ï Troublesome in one condition but useful in others.
ï Ex. atropine
ï±UNTOWARD EFFECTSï Undesirable effects with therapeutic dose of the drug ,if severe requires
caessation of treatment.
ï Ex.tetracyclines,aspirin
ï±TOXIC EFFECTSï Effects produced by large & / repeated doses
ï Ex. morphine
14. Comparison âtype A &B
Type A
Type B
1.Nature
augmented/ attenuated normal Totally abnormal, bizarre
response
2.Mechanism
Hyper/ hypo response
Genetic, immunological,UK
3. Predictable
Yes
No
4.Incidence
high
Low
5.Mortality
Low
High
6. Treatment
Adjust dose
Stop the drug
7.Dose dependent
Yes
No
16. ALLERGIC REACTION
FEATURES
1. Ranges from mild- severe (anaphylaxis)
2. Prior sensitization requried
3. Immunologically mediated
4. Low incidence , unpredictable, dose
independent.
17. Hypersensitivity
Hypersensitivity is an immune reaction to
innocuous antigens that results in tissue injury
and/or disease
An antigen that causes allergy is an allergen
18. TYPES OF ALLERGIC REACTIONS
I.IgE MEDIATED REACTION AND
ANAPHYLAXIS-(immediate hypersensitivity)
âą Systemic anaphylaxis- ex.penicillin.
Antigen + IgE antibodiesâinflux of ca++ ----degranulation of mast
cells ,basophilesârelease of histamine---anaphylaxis
âą Local anaphylaxis -Hay fever
-Asthma
-Diarrhea, gi.Pain.
-Skin rash
19. Allergy (type I hypersensitivity mediated
by IgE on mast cells)
22. TYPE II ALLRGIC REACTION
Cytotoxic type reactionAntibodies binds to antigen present on the cell surface
promotes phagocytosis of cell or cell destruction by
polymorphs, macrophages or by lymphoid killer cells.
ExamplesTransfusion reactions
Rh incompatibility
âą drugs-antigenic complex with blood cells----increase
humoral antibodies----cytotoxic â
haemolysis / agranulocytosis / thrombocytopenia
23. Type II hypersensitivity (IgG-mediated anticell-associated antigen response) is rare
Immune response to certain drugs (e.g.,
penicillin) where drug binds to cell surface and
antibody cause removal of the cells (usually
by macrophages).
24. TYPE III
IMMUNE COMPLEX MEDIATED REACTIONS
ANTIGEN+HUMORAL ANTIBODIES
IMMUNE COMPLEXES
Ab EXCESS
Ppt.NEAR SITE OF ENTRY
SKIN-ERYTHEMA,EDEMA, ETC.
ARTHUS REACTION
Ag EXCESS
DEPOSIT IN SKIN, JOINTS
KIDNEY
SERUM SICKNESS
29. Risk Factors for Adverse Drug Reactions
Simultaneous use of several different drugs
â Drug-drug interactions
Very young, or very old in age
Pregnancy
Breast Feeding
Hereditary Factors
Disease states which may effect drug absorption,
metabolism, and/or elimination
32
30. Risk Factors Examples: Simultaneous Drug Use or
Drug-Drug Interactions
Cerivastatin-Gemfibrozil interactions in
hypercholesterolemia patients (rhabdomyolysis)
Coumadin-NSAID interactions (increased inhibition of
platelet aggregation)
Venlafaxine-indinavir interactions in depressed HIVinfected patients (decreased indinavir concentrations)
33
31. Risk Factors Examples: Age Related Issues
Children are often at risk because their capacity to
metabolize drugs is usually not fully developed
â Newborns cannot metabolize or eliminate chloramphenicol, an
antibiotic
â Children younger than 18 may be at risk of developing Reyeâs
syndrome if given acetylsalicylic acid (aspirin) while infected with
chickenpox or influenza
â Central nervous system effects of topiramate in children
(seizures, tremor, and dizziness)
34
32. Risk Factors Examples: Age Related
Issues
ïŹ ADRs, including drug interactions, are a common cause of
admission to hospitals in the elderly
ïŹ Reasons for ADRs in the elderly:
â Concomitant use of several medications
â Disease states leading to drug ADME changes
â Decreased drug ADME activity due to age
ïŹ These conditions are exacerbated by malnutrition and
dehydration, common in the elderly
35
33. Risk Factors Examples: Pregnancy
ïŹ Use of sulfonamides (antibiotic) can lead to
jaundice and brain damage in the fetus
ïŹ Warfarin use for anticoagulation can lead to birth
defects, and increased risk of bleeding problems in
newborns and mothers
ïŹ Lithium, for bipolar disorder, can lead to defects of
the heart, lethargy, reduced muscle tone, and
underactivity of the thyroid gland
36
34. Risk Factors Examples: Breastfeeding
ïŹ Similar concerns, as for other children with
underdeveloped capability to metabolize or excrete
xenobiotics
ïŹ Many drugs can be passed from mother to infant
via breast milk
â Amantadine (antiviral)
â Cyclophosphamide (antineoplastic)
â Cocaine (Schedule 2 FDA drug)
â Carisoprodol (skeletal muscle relaxant)
37
35. Risk Factors Examples: Hereditary
Factors
ïŹ Genetic polymorphisms may play a role
â Evident in CYP2C9 and 2C19, especially in the Asian population
(phenytoin)
â May lead to impaired metabolism in mutation of enzymes
ïŹ Higher risk of hemolysis in some populations, such as
African, Middle Eastern, and South East Asian races
â Quinolones
â Antimalarials
38
36. Risk Factors Examples: Disease States
ïŹ Metabolism (Phase I or II) may be impaired with
hepatic disease
â Cirrhosis
â Hepatic Carcinoma
ïŹ Renal Insufficiency
â Acute or Chronic Renal Failure
â Decreased glomerular filtration rate (GFR)
ïŹ Drug levels may become toxic if too high, so
dosing modifications may be indicated
39
Hinweis der Redaktion
igen
Make comment about diphenhydramine and sedation (positive outcome)
Also about retonovir and ropenivir (retonovir increases concentrations of ropenivir, resulting in higher drug concentrations = lower doses)
Thalidomide example for risk in pregnancy (resulted in severe birth defects). Now used in the treatment of multiple myeloma, although efficacy not fully established